metoprolol
FDA Approved
Description
Metoprolol is a selective beta-1 adrenergic receptor blocker used to manage cardiovascular conditions. It reduces myocardial oxygen demand and heart rate, which can be beneficial in managing symptoms of anomalous coronary artery anatomy. The drug is widely used for angina, hypertension, and heart failure.
Indications & Therapeutic Use
hypertension, angina pectoris, myocardial infarction, heart failure
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
metoprolol
| Generic Name | metoprolol |
| Brands | 1 brand available |
| Active Ingredient | metoprolol tartrate |
| Drug Class | hypertension |
| Manufacturer | Novartis |
| Dosage Forms | oral tablet 25mg, 50mg, 100mg; extended-release tablet; IV injection |
| Medical Code | C07AB02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 2 days |
| Reg. Status | FDA Approved |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes